Filing Details
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2009-05-26 17:41:28
- Reporting Period:
- 2009-05-22
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1340752 | Molecular Insight Pharmaceuticals Inc. | MIPI | () |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1410709 | E. Donald Wallroth | Molecular Insight Pharmaceuticals 160 Second Street Cambridge MA 02142 | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2009-05-22 | 4,000 | $3.80 | 16,000 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Billionaire Hedge Funds
